Literature DB >> 21256761

Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity.

Giuseppe D'Ancona1, Federico Bertuzzi, Lucia Sacchi, Francesco Pirone, Vincenzo Stringi, Antonio Arcadipane, Riccardo Bellazzi, Michele Pilato.   

Abstract

OBJECTIVE: Evaluation of the effects of tight glycemia control in critically ill patients should include temporal as well as punctual glycemia data.
METHODS: Insulin drip was used to target intensive care unit (ICU) glucose levels between 80 and 126 mg dl⁻¹ in a consecutive series of adult cardiac surgery patients. ICU hourly glycemia was prospectively recorded. Glycemia standard deviation, hyperglycemia index (area under the curve for glycemia>126 mg dl⁻¹ divided by total hours in ICU), and hypoglycemic episodes were recorded and analyzed, together with outcomes.
RESULTS: A total of 596 patients were included. Hypoglycemia occurred in 21% of the patients. In-hospital mortality was 2.6%. There was a univariate correlation between mortality and glycemia standard deviation, and hypoglycemia occurrence. At multivariate analysis, hypoglycemia was a determinant for mortality (p=0.002; odds ratio (OR)=20.0), respiratory failure (p=0.0001; OR=1.4), requirement of a tracheostomy (p=0.0001; OR=21.6), and hemodynamic instability requiring intra-aortic balloon pump (IABP) (p=0.01; OR=1.5). To clarify the determinants of hypoglycemia, a second multivariate model was built. Diabetes (p=0.0001; OR=23) and chronic renal failure (p=0.01; OR=25) were the sole determinants for hypoglycemia occurrence.
CONCLUSION: Iatrogenic hypoglycemia secondary to ICU tight glycemia control correlates with hospital mortality, respiratory, and cardiac morbidity in patients undergoing cardiac surgery. ICU hyperglycemia index and glycemia temporal variability have no independent correlation with outcomes. Higher glycemia targets should be advised in the perioperative management of patients with diabetes and renal failure, as both conditions independently increase the risk of hypoglycemia occurrence.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256761     DOI: 10.1016/j.ejcts.2010.11.065

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.

Authors:  Maya Fayfman; Rodolfo J Galindo; Daniel J Rubin; Dara L Mize; Isabel Anzola; Maria A Urrutia; Clementina Ramos; Francisco J Pasquel; J Sonya Haw; Priyathama Vellanki; Heqiong Wang; Bonnie S Albury; Rita Weaver; Saumeth Cardona; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2019-01-24       Impact factor: 19.112

Review 2.  Hypoglycemia Reduction Strategies in the ICU.

Authors:  Susan Shapiro Braithwaite; Dharmesh B Bavda; Thaer Idrees; Faisal Qureshi; Oluwakemi T Soetan
Journal:  Curr Diab Rep       Date:  2017-11-02       Impact factor: 4.810

Review 3.  Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Curr Opin Pharmacol       Date:  2012-02-09       Impact factor: 5.547

Review 4.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

Review 5.  Blood glucose measurement in the intensive care unit: what is the best method?

Authors:  Huong T Le; Neil S Harris; Abby J Estilong; Arvid Olson; Mark J Rice
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

6.  Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.

Authors:  Rajesh Garg; Brooke Schuman; Shelley Hurwitz; Cheyenne Metzger; Shreya Bhandari
Journal:  BMJ Open Diabetes Res Care       Date:  2017-03-29

7.  Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients.

Authors:  Nobutoshi Fushimi; Takashi Shibuya; Yohei Yoshida; Shun Ito; Hiroki Hachiya; Akihiro Mori
Journal:  J Diabetes Investig       Date:  2019-06-28       Impact factor: 4.232

8.  Hypoglycemia Is Associated With Worse Outcomes in Patients With Cholangitis Despite Undergoing Endoscopic Retrograde Cholangiopancreatography.

Authors:  Adham E Obeidat; Ratib Mahfouz; Kevin Benavente; Landon A Kozai; Mahmoud M Mansour; Mohammad Darweesh; Nikolaos T Pyrsopoulos
Journal:  Cureus       Date:  2022-07-18

9.  Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study).

Authors:  Luis M Pérez-Belmonte; Juan J Gómez-Doblas; Mercedes Millán-Gómez; María D López-Carmona; Ricardo Guijarro-Merino; Fernando Carrasco-Chinchilla; Eduardo de Teresa-Galván; Manuel Jiménez-Navarro; M Rosa Bernal-López; Ricardo Gómez-Huelgas
Journal:  J Clin Med       Date:  2018-09-11       Impact factor: 4.241

10.  Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.

Authors:  Saumeth Cardona; Katerina Tsegka; Francisco J Pasquel; Maya Fayfman; Limin Peng; Sol Jacobs; Priyathama Vellanki; Michael Halkos; Robert A Guyton; Vinod H Thourani; Rodolfo J Galindo; Guillermo Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2019-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.